Trials / Unknown
UnknownNCT03280316
Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery
Efficacy Comparison Between Different Management Strategies for Consistent Overactive Bladder (OAB) in Patients With Spinal Vascular Malformations After Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Xuanwu Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators' goal is to compare the efficacy of three different management strategies (sacral neuromodulation, botulinum toxin, M receptor antagonist) in treating consistent OAB in patients with SVMs after surgery.
Detailed description
Spinal Vascular malformations (SVMs) are complex neurosurgical lesions and account for 3%-4% of all intradural spinal cord mass lesions, which can influence the function of bladder. The investigators' goal is to compare the efficacy of three different management strategies (sacral neuromodulation, botulinum toxin, M receptor antagonist) in treating consistent OAB (Overactive Bladder) in patients with SVMs after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | surgery | patients with SVMs receive surgery |
| PROCEDURE | sacral neuromodulation | sacral neuromodulation (SNM) with InterStimTM |
| PROCEDURE | botulinum toxin A injection | BOTOX |
| DRUG | M receptor antagonist | Tolterodine |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-10-01
- Completion
- 2023-12-01
- First posted
- 2017-09-12
- Last updated
- 2020-04-29
Source: ClinicalTrials.gov record NCT03280316. Inclusion in this directory is not an endorsement.